Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%

Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM). In a new filing with the Securities and Exchange Commission, Camber Capital disclosed a 5.41% passive stake in the company, containing 6.30 million shares, up from 2.91 million shares held previously.

Sequenom, Inc. (NASDAQ:SQNM)

Sequenom Inc. (NASDAQ:SQNM) is a life sciences company engaged in improving healthcare through revolutionary genomic and genetic analysis solutions. The company has a market cap of $422.5 million. At the end of last month, the company said it completed the sale of its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners. Under the agreement, Sequenom Inc. (NASDAQ:SQNM) will receive $31.8 million, subject to certain adjustments, and may also receive up to $4 million in contingent consideration upon the achievement of certain regulatory and sales milestones, according to a statement.

For the first quarter of 2014, the company posted a net loss of $15.7 million, or $0.13 per share, compared to net loss of $29.4 million, or $0.26 per share, for the same period of 2013. Adjusted net loss for the first quarter was $14.7 million, or $0.13 per share. The company reported revenue of $46.3 million for the first quarter, representing an increase of 20% compared to revenue of $38.5 million for the first quarter of 2013. Revenues from diagnostic services was up 27%, compared to the first quarter of 2013, and 13% on a sequential basis over the fourth quarter of 2013.

On Monday, the company’s stock rose 0.97% to $3.62. It has a 52 week high of $4.90 and a 52 week low of $1.65. The consensus average target price is $4.63 on the stock, while the consensus average recommendation is ‘overweight.’

In addition to Camber Capital, other significant shareholders of Sequenom Inc. (NASDAQ:SQNM) include William Leland Edwards‘ Palo Alto Investors and Youlia Miteva’s Proxima Capital Management, owning 9.79 million shares and 2.21 million shares, respectively.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!